4 GARP Stocks With Attractive PEG Ratios and Strong Growth OutlooksZacks Investment Research • 01/29/26
Is Harmony Biosciences (HRMY) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 01/29/26
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed?The Motley Fool • 01/27/26
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Harmony Biosciences (HRMY) is an Incredible Growth Stock: 3 Reasons WhyZacks Investment Research • 01/13/26
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value CreationBusiness Wire • 01/12/26
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/07/26
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEGGlobeNewsWire • 12/16/25
Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet SyndromeBusiness Wire • 12/08/25
Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual MeetingBusiness Wire • 12/02/25
Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant FormulationBusiness Wire • 11/24/25
Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist (BP1.15205) for Central Disorders of HypersomnolenceBusiness Wire • 11/19/25
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss EstimatesZacks Investment Research • 11/04/25
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865MBusiness Wire • 11/04/25
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 10/28/25
Harmony Biosciences (HRMY) Moves 12.7% Higher: Will This Strength Last?Zacks Investment Research • 10/24/25
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue GuidanceBusiness Wire • 10/23/25